Study Evaluating Bifeprunox in Bipolar Depression

NCT00245973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression Bipolar

Interventions

DRUG: Bifeprunox

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]